Pursuant to Regulation 74(5) of Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018., Nectar Lifesciences has informed that it enclosed a copy of the Certificate received from Kfin Technologies, Registrar and Share Transfer Agent of the Company for the quarter ended on December 31, 2025.
The above information is a part of company’s filings submitted to BSE.